yulong he - Search Results

Year	Number of Results
2002	2
2003	4
2004	6
2005	8
2006	15
2007	12
2008	11
2009	20
2010	12
2011	18
2012	27
2013	25
2014	34
2015	25
2016	30
2017	22
2018	34
2019	29
2020	40
2021	59
2022	65
2023	54
2024	16

1

NIFK, a Potential Prognostic and Immunological Biomarker in Pan-- Cancer Analysis, Significantly Regulates Proliferation and Metastasis of Colorectal Cancer.

Li Z, Zhou S, Bin T, Shi Y, Zeng L, Li B, Li J, He Y, Zhang C. Li Z, et al. Among authors: he y. Recent Pat Anticancer Drug Discov. 2024 Apr 24. doi: 10.2174/0115748928295346240406185103. Online ahead of print. Recent Pat Anticancer Drug Discov. 2024. PMID: 38659266

2

A Mitochondria-Targeted Nitric Oxide Probe for Multimodality Imaging of Macrophage Immune Responses.

Wen Y, Wu X, Wu W, Feng T, Pan Y, He Y, Ji L, Chao H. Wen Y, et al. Among authors: he y. Anal Chem. 2024 Apr 30;96(17):6666-6673. doi: 10.1021/acs.analchem.4c00083. Epub 2024 Apr 16. Anal Chem. 2024. PMID: 38623755

3

Perioperative versus adjuvant S-1 plus oxaliplatin chemotherapy for stage II/III resectable gastric cancer (RESONANCE): a randomized, open-label, phase 3 trial.

Wang X, Lu C, Wei B, Li S, Li Z, Xue Y, Ye Y, Zhang Z, Sun Y, Liang H, Li K, Zhu L, Zheng Z, Zhou Y, He Y, Li F, Wang X, Liang P, Huang H, Li G, Shen X, Ji J, Tang Y, Xu Z, Chen L; RESONANCE study group. Wang X, et al. Among authors: he y. J Hematol Oncol. 2024 Apr 8;17(1):17. doi: 10.1186/s13045-024-01536-7. J Hematol Oncol. 2024. PMID: 38589926 Free PMC article. Clinical Trial.

4

Exosome circATP8A1 induces macrophage M2 polarization by regulating the miR-1-3p/STAT6 axis to promote gastric cancer progression.

Deng C, Huo M, Chu H, Zhuang X, Deng G, Li W, Wei H, Zeng L, He Y, Liu H, Li J, Zhang C, Chen H. Deng C, et al. Among authors: he y. Mol Cancer. 2024 Mar 8;23(1):49. doi: 10.1186/s12943-024-01966-4. Mol Cancer. 2024. PMID: 38459596 Free PMC article.

5

RNA methylation-related genes INHBB and SOWAHA are associated with MSI status in colorectal cancer patients and may serve as prognostic markers for predicting immunotherapy efficacy.

Yin Y, Yang S, Huang Z, Yang Z, Zhang C, He Y. Yin Y, et al. Among authors: he y. Carcinogenesis. 2024 Feb 24:bgae004. doi: 10.1093/carcin/bgae004. Online ahead of print. Carcinogenesis. 2024. PMID: 38400766

6

Combined Hepatocellular-Cholangiocarcinoma: Biology, Diagnosis, and Management.

Ye L, Schneider JS, Ben Khaled N, Schirmacher P, Seifert C, Frey L, He Y, Geier A, De Toni EN, Zhang C, Reiter FP. Ye L, et al. Among authors: he y. Liver Cancer. 2023 Apr 24;13(1):6-28. doi: 10.1159/000530700. eCollection 2024 Feb. Liver Cancer. 2023. PMID: 38344449 Free PMC article. Review.

7

Integrating cfDNA liquid biopsy and organoid-based drug screening reveals PI3K signaling as a promising therapeutic target in colorectal cancer.

Yang H, Xiao X, Zeng L, Zeng H, Zheng Y, Wang J, Li G, Dai W, He Y, Wang S, Peng J, Chen W. Yang H, et al. Among authors: he y. J Transl Med. 2024 Feb 3;22(1):132. doi: 10.1186/s12967-023-04675-6. J Transl Med. 2024. PMID: 38310289 Free PMC article.

8

The Chinese Hamster Ovary Cell-Based H9 HA Subunit Avian Influenza Vaccine Provides Complete Protection against the H9N2 Virus Challenge in Chickens.

Zhu S, Nie Z, Che Y, Shu J, Wu S, He Y, Wu Y, Qian H, Feng H, Zhang Q. Zhu S, et al. Among authors: he y. Viruses. 2024 Jan 22;16(1):163. doi: 10.3390/v16010163. Viruses. 2024. PMID: 38275973 Free PMC article.

9

Corrigendum to "Downregulation of CYRI-B promotes migration, invasion and EMT by activating the Rac1-STAT3 pathway in gastric cancer" [423(2023)/113453].

Liu G, Xia Y, Wang H, Jin X, Chen S, Chen W, Zhang C, He Y. Liu G, et al. Among authors: he y. Exp Cell Res. 2024 Feb 1;435(1):113890. doi: 10.1016/j.yexcr.2023.113890. Epub 2024 Jan 12. Exp Cell Res. 2024. PMID: 38217935 No abstract available.

10

The feedback loop of EFTUD2/c-MYC impedes chemotherapeutic efficacy by enhancing EFTUD2 transcription and stabilizing c-MYC protein in colorectal cancer.

Zhu X, Li C, Gao Y, Zhang Q, Wang T, Zhou H, Bu F, Chen J, Mao X, He Y, Wu K, Li N, Luo H. Zhu X, et al. Among authors: he y. J Exp Clin Cancer Res. 2024 Jan 2;43(1):7. doi: 10.1186/s13046-023-02873-0. J Exp Clin Cancer Res. 2024. PMID: 38163859 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

519 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

519 results

Results by year